A female patient aged 73 presented with a history of general malaise and hyperpigmentation. Iron studies in the patient and immediate family members indicated that the proband was homozygous for haemochromatosis, but subsequent investigations revealed that porphyria cutanea tarda was responsible for her signs and symptoms. Venesection of four units of blood brought her symptoms under control. The interplay between porphyria cutanea tarda and excess iron deposition is discussed as is the role of extending investigations to first and second degree relatives when either haemochromatosis or porphyria cutanea tarda is suspected.
A woman aged 73 years was admitted to hospital in June 1987 complaining of anorexia and general malaise for three months. She had always had a 'dark complexion', but in the last three months the pigmentation had become more pronounced over the light exposed areas of her face and arms, despite minimal sun exposure. She also commented on an increase in hair on the upper lip and over the temples.
A working diagnosis ofhaemochromatosis was arrived at on the following evidence: serum ferritin 636 [tg/l (normal range 20-300 ,ug/l); serum iron 63 ,umol/l (normal range [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [tmol/l); transferrin saturation 94% (normal range 20-50%); and a history of adult onset diabetes mellitus. This diagnosis seemed to be supported by a liver biopsy specimen which showed moderate fatty change with excessive deposition of coarse iron granules in hepatocytes and Kupffer cells throughout most of the hepatic lobule (grade [3] [4] Figure shows the proband (II-3) had a brother (II-4) aged 68 whose transferrin saturation was 55%, suggesting heterozygosity for the haemochromatosis gene.' The proband's sister (II-1) was aged 65 and had a transferrin saturation of 32%, which although in the normal range is also compatible with heterozygosity. It is customary to screen siblings of patients with haemochromatosis as they are at a 25% risk of being homozygotes. The haemochromatosis gene is common in the general population, approximately 10% of whites being carriers,2" and so wider screening of second degree relatives is also logical.5 The proband's only son declined to be tested and is therefore not shown in the figure, but the proband's niece (III-1) had a transferrin saturation of 98% with a serum ferritin concentration of 484 [tg/l. It is therefore highly likely that she is homozygous for the haemochromatosis gene.' She was not pigmented, but had developed a non-erosive seronegative arthropathy in November 1987 which may have been due to iron deposition. She had a history of menorrhagia which may have protected her from the more serious effects of iron overload. She also had congenital absence of a breast, but this is usually a sporadic event and was not thought to be related to her haemochromatosis. We concluded that the niece (III-1) had inherited one haemochromatosis gene from her mother (II-1) and one from her late father (II-2). HLA typing of the family indicated that her father must have had the haplotype A3, B7, which is commonly associated with haemochromatosis.15 6 Seymour, Elder induce a remission in the porphyria cutanea tarda.8 ' 1 A diagnosis of porphyria cutanea tarda would also explain the proband's facial hirsutism. Although urine porphyrin screening had been normal on initial assessment, a repeat investigation showed a pattern of increased porphyrin excretion that was diagnostic: total urinary porphyrin 1560 nmol/l (mainly uroporphyrin and heptacarboxylic porphyrin; normal range 20-320 nmol/l) with an increased concentration of isocoproporphyrin in the faeces.
To add further support to the diagnosis of porphyria cutanea tarda in the proband, unstained formalin fixed paraffin sections of the liver biopsy specimens from 1983 and 1987 were examined under polarised light for porphyrin crystals. None were found in the first biopsy specimen, but several small, needle shaped crystals typical of porphyria cutanea tarda were present in the hepatocytes in the second specimen. These crystals are water soluble and are easily dissolved out of the tissues during routine fixation, which may explain the failure to find them in the earlier biopsy specimen. The diagnosis of porphyria cutanea tarda in the proband was therefore established on biochemical and histological grounds. In the 12 months after the diagnosis was established four venesections of 500 ml each achieved clinical remission of the porphyria cutanea tarda and returned the ferritin level to normal.
Porphyrin studies in the proband's sister (II-1) and niece (III-1) were normal (total urinary porphyrin concentration <65 nmol/l; faecal porphyrin concentration <95 nmol/g dry weight with no detectable isocoproporphyrin). Uroporphyrinogen decarboxylase concentrations in erythrocytes from the proband, her sister, and her niece ranged from 71-108% of the mean concentration in control subjects. The Several points for general clinical practice also emerge from this report. Porphyria cutanea tarda can present in old age. While mechanical fragility, blistering, and scarring of the skin are the most common findings, increased pigmentation over areas exposed to the sun may be the only skin findings, as in the present case. As this report also shows, porphyria cutanea tarda is not always detected by urine screening tests.'9 If clinical suspicion is high the diagnosis should not be rejected unless urinary uroporphyrin and faecal isocoproporphyrin concentrations are normal. In view of the frequent association of porphyria cutanea tarda with hepatic iron overload, and because porphyrin crystals may be seen easily in unstained liver biopsy specimens, we suggest that these crystals should be searched for routinely in all liver biopsy specimens showing excessive iron deposition.
